This is the authors' abstract. We don't add key points for this paper.
Dementia primarily affects an individual's cognitive function and many aspects of life are negatively affected by cognitive decline. There are no approved disease-modifying drugs and no approved prevention strategies for dementia; a heavy burden is placed on the individual who has dementia, their family, and society. In The Lancet Neurology, a report1 from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016 Dementia Collaborators presents estimates of dementia-related deaths, prevalence, quality of life measures, and risk factors, with the aim of documenting global patterns and providing data for research, and to guide a wide range of public health investments.
No takes yet. Share an insight, caveat, or question.
Lenore J. Launer (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: